Published Jun 1, 2018
John 2018
24 Posts
Can anybody help the following question?
In Australia, Oxycondone controlled release has two different brands:
Oxycodone Sandoz Controlled release tablets, 5 mg, 10 mg, 20 mg, 40 mg, 80 mg.
OxyContin Reformulated Modified release tablets, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 80 mg.
Above two brands contain the same medication Oxycondone controlled release , but with difference strengths.
In the ward register, should a different brand use a different page? or should these two brands be mixed together as the same medication Oxycontin on the same page in the ward register?
Please advise.
Thanks.
For example, both brands have the same strength 10 mg.
Should Oxycodone Sandoz Controlled release tablets 10 mg be documented on the same page as OxyContin Reformulated Modified release tablets 10 mg in the ward register?
Or should Oxycodone Sandoz Controlled release tablets 10 mg be documented on a difference page ? In other words, Oxycodone Sandoz Controlled release tablets 10 mg to be documented on one page, and OxyContin Reformulated Modified release tablets 10 mg to be documented on another different page.
JKL33
6,953 Posts
Hopefully someone will come along who knows about your exact situation, but my best guess in the meantime would be that it if you're completely on paper, there probably should be some indication whether the patient received the generic or brand. Seems like this would be prudent to cover bases should there be a problem with one of the lots or the patient has some kind of reaction or something (?)
Probably easiest to keep track on separate sheets.
This question came from online research. It didn't come from practice.
In other words, it is a scenario for others to share experiences together on the forum.
meanmaryjean, DNP, RN
7,899 Posts
I think that would be a question for your pharmacist. Here in the States it would be anyhow.
sirI, MSN, APRN, NP
17 Articles; 45,819 Posts
Duplicate threads merged
caliotter3
38,333 Posts
I know how I would do this based upon policy, but I doubt it is done the same way in Australia. You need to ask supervisory personnel at your facility to clarify their policy.
In Australia, a separate page of the ward register should be used for each brand name and each strength generally. Also, facility policies need to be checked.
How is the same scenario going in other countries such as New Zealand, Canada, UK and Ireland?
heron, ASN, RN
4,405 Posts
Oxycodone and oxycontin are not the same. The first is immediate release and short acting ( 3 - 6 hr.) and may be prescribed prn or scheduled. The second is an extended release version (8 - 12 hours) and should not be prescribed prn. Confusing the two could lead either to overdose or severely undertreated pain. No bueno.
Therefore, i would expect to document on a different page.
Well, that is what we are familiar with, but that clearly seems not to be the case here since you can google the two preparations he is talking about and neither one of them are IR.
My mistake - reading too fast:unsure:
Silverdragon102, BSN
1 Article; 39,477 Posts
Where I work each resident has their own page and own drugs where tally is kept plus a condensed sheet with a tally on all narcotic drugs in the locked cupboard which is checked each time there is a shift change